{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:16Z","timestamp":1761058516396},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1080\/00313020600820732","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T17:27:57Z","timestamp":1155835677000},"page":"343-348","source":"Crossref","is-referenced-by-count":4,"title":["In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia"],"prefix":"10.1016","volume":"38","author":[{"given":"Iain B.","family":"Gosbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence J.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/00313020600820732_bib005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3201\/eid0506.990603","article-title":"Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-1998","volume":"5","author":"Doern","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1080\/00313020600820732_bib0010","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1080\/00313020600820732_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0732-8893(00)00125-5","article-title":"In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY antimicrobial surveillance program, 1997-1998","volume":"37","author":"Jones","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1080\/00313020600820732_bib0020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1080\/00313020600820732_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.320.7229.213","article-title":"Bacteraemia and antibiotic resistance of pathogens reported in England and Wales between 1990 and 1998: trend analysis","volume":"320","author":"Reacher","year":"2000","journal-title":"Br Med J"},{"key":"10.1080\/00313020600820732_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000239555","article-title":"Increase in high resistance to penicillin of clinical isolates of Streptococcus pneumoniae in Cadiz, Spain","volume":"43","author":"Garcia-Martos","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1080\/00313020600820732_bib0035","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/AAC.43.11.2612","article-title":"Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study","volume":"43","author":"Thornsberry","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib0040","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.5694\/j.1326-5377.2000.tb139418.x","article-title":"Antibiotic resistance in Streptococcus pneumoniae","volume":"173","author":"Collignon","year":"2000","journal-title":"Med J Aust"},{"key":"10.1080\/00313020600820732_bib0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults: Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600820732_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Hellfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1080\/00313020600820732_bib0055","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1128\/AAC.44.7.1838-1841.2000","article-title":"Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin and trovafloxacin against erythromycin-susceptible and resistant streptococci","volume":"44","author":"Betriu","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/AAC.41.2.488","article-title":"In vitro activity and spectrum of LY333328, a novel glycopeptide derivative","volume":"41","author":"Jones","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib0065","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/AAC.44.5.1370-1374.2000","article-title":"In vitro activities of LY333328 and comparative agents against nosocomial Gram-positive pathogens collected in a global surveillance study","volume":"44","author":"Zeckel","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5694\/j.1326-5377.1999.tb127710.x","article-title":"Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia","volume":"170","author":"Turnidge","year":"1999","journal-title":"Med J Aust"},{"key":"10.1080\/00313020600820732_bib0075","first-page":"340","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: a decade of results from south-western Sydney","volume":"24","author":"Gosbell","year":"2000","journal-title":"Commun Dis Intel"},{"key":"10.1080\/00313020600820732_bib0080","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","article-title":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2003"},{"key":"10.1080\/00313020600820732_bib0085","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement: Approved standard M100-S15","article-title":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2005"},{"issue":"Suppl. 3","key":"10.1080\/00313020600820732_bib0090","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/321847","article-title":"Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the Unites States","volume":"33","author":"Doern","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600820732_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/clinids\/15.1.112","article-title":"Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding profile, surface protein A typing and multilocus enzyme analysis","volume":"15","author":"Munoz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600820732_bib00100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/45.4.457","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolates in Asia and Europe, 1997-1998","volume":"45","author":"Sahm","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1080\/00313020600820732_bib00105","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1469-0691.1997.tb00646.x","article-title":"The role of fourth- generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci","volume":"3","author":"Klugman","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1080\/00313020600820732_bib00110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/367545","article-title":"What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?","volume":"36","author":"File TM","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600820732_bib00115","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","article-title":"Resistance to macrolides and related antibiotics in Streptococcus pneumoniae","volume":"46","author":"Leclercq","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib00120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bmj.308.6922.191","article-title":"Dangers of oral quinolone treatment in community acquired upper respiratory tract infections","volume":"308","author":"Korner","year":"1994","journal-title":"Br Med J"},{"key":"10.1080\/00313020600820732_bib00125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/47.4.411","article-title":"Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales","volume":"47","author":"Johnson","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313020600820732_bib00130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1080\/00313020600820732_bib00135","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib00140","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1128\/AAC.45.10.2955-2957.2001","article-title":"Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones","volume":"45","author":"Alou","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib00145","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/AAC.47.2.804-808.2003","article-title":"Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada","volume":"47","author":"Nichol","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313020600820732_bib00150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/341900","article-title":"The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?","volume":"35","author":"Mandell","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313020600820732_bib00155","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1086\/344768","article-title":"Widespread use of fluoroquinolones versus emerging resistance in pneumococci","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:02:42Z","timestamp":1587164562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516339174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0031302516339174"],"URL":"https:\/\/doi.org\/10.1080\/00313020600820732","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}